✦ LIBER ✦
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β : An Italian Sarcoma Group study
✍ Scribed by Giovanni Grignani; Emanuela Palmerini; Silvia Stacchiotti; Antonella Boglione; Virginia Ferraresi; Sergio Frustaci; Alessandro Comandone; Paolo G Casali; Stefano Ferrari; Massimo Aglietta
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 170 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.